MNPR vs. CALX
MNPR (Monopar Therapeutics Inc.) and CALX (Calix, Inc.) are both stocks. MNPR operates in Biotechnology (Healthcare), while CALX operates in Software - Application (Technology). Over the past 5 years, MNPR returned 20.30%/yr vs -5.07%/yr for CALX. At a 0.12 correlation, their price movements are largely independent.
Performance
MNPR vs. CALX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MNPR achieves a 25.22% return, which is significantly higher than CALX's -31.31% return.
MNPR
- 1D
- 19.09%
- 1M
- 29.55%
- YTD
- 25.22%
- 6M
- 15.99%
- 1Y
- 156.90%
- 3Y*
- 165.89%
- 5Y*
- 20.30%
- 10Y*
- —
CALX
- 1D
- -2.96%
- 1M
- -7.32%
- YTD
- -31.31%
- 6M
- -34.40%
- 1Y
- -24.91%
- 3Y*
- -9.21%
- 5Y*
- -5.07%
- 10Y*
- 18.36%
MNPR vs. CALX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
MNPR Monopar Therapeutics Inc. | 25.22% | 196.82% | 1,193.36% | -85.65% | -26.17% | -47.55% | -63.13% | 98.80% |
CALX Calix, Inc. | -31.31% | 51.79% | -20.19% | -36.15% | -14.43% | 168.72% | 272.00% | 0.50% |
Correlation
The correlation between MNPR and CALX is 0.10, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.10 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.15 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.13 |
Correlation (All Time) Calculated using the full available price history since Dec 19, 2019 | 0.12 |
Fundamentals
MNPR:
$697.91M
CALX:
$2.38B
MNPR:
-$532.10
CALX:
$0.51
MNPR:
0.01
CALX:
3.23
MNPR:
$0.00
CALX:
$1.06B
MNPR:
$0.00
CALX:
$604.90M
MNPR:
-$5.24B
CALX:
$60.25M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MNPR vs. CALX — Risk / Return Rank
MNPR
CALX
MNPR vs. CALX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Monopar Therapeutics Inc. (MNPR) and Calix, Inc. (CALX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MNPR | CALX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.58 | ||
| Sortino ratioReturn per unit of downside risk | +3.41 | ||
| Omega ratioGain probability vs. loss probability | 1.32 | 0.91 | +0.41 |
| Calmar ratioReturn relative to maximum drawdown | 3.10 | -0.53 | +3.64 |
| Martin ratioReturn relative to average drawdown | 4.98 | -1.09 | +6.07 |
Loading charts...
Drawdowns
MNPR vs. CALX - Drawdown Comparison
The maximum MNPR drawdown since its inception was -98.93%, which is greater than CALX's maximum drawdown of -80.95%. Use the drawdown chart below to compare losses from any high point for MNPR and CALX.
Loading charts...
Drawdown Indicators
| MNPR | CALX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.93% | -80.95% | -17.98% |
Max Drawdown (1Y)Largest decline over 1 year | -50.89% | -46.86% | -4.03% |
Max Drawdown (3Y)Largest decline over 3 years | -71.07% | -46.86% | -24.21% |
Max Drawdown (5Y)Largest decline over 5 years | -95.45% | -65.32% | -30.13% |
Max Drawdown (10Y)Largest decline over 10 years | — | -65.32% | — |
Current DrawdownCurrent decline from peak | -39.43% | -54.53% | +15.10% |
Average DrawdownAverage peak-to-trough decline | -80.14% | -49.36% | -30.78% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 31.61% | 22.96% | +8.65% |
Volatility
MNPR vs. CALX - Volatility Comparison
Monopar Therapeutics Inc. (MNPR) has a higher volatility of 19.63% compared to Calix, Inc. (CALX) at 8.36%. This indicates that MNPR's price experiences larger fluctuations and is considered to be riskier than CALX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MNPR | CALX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 19.63% | 8.36% | +11.27% |
Volatility (6M)Calculated over the trailing 6-month period | 45.55% | 33.15% | +12.40% |
Volatility (1Y)Calculated over the trailing 1-year period | 81.51% | 39.29% | +42.22% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 296.19% | 49.16% | +247.03% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 277.36% | 51.37% | +225.99% |
Dividends
MNPR vs. CALX - Dividend Comparison
Neither MNPR nor CALX has paid dividends to shareholders.
Financials
MNPR vs. CALX - Financials Comparison
This section allows you to compare key financial metrics between Monopar Therapeutics Inc. and Calix, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
MNPR and CALX have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MNPR has higher volatility (19.63%) compared to CALX (8.36%). In terms of maximum drawdown, MNPR dropped -98.93% vs CALX's -80.95%.
MNPR currently has the higher Sharpe Ratio (1.94 vs -0.64), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MNPR and CALX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer